{
    "2018-11-09": [
        [
            {
                "time": "2018-11-05",
                "original_text": "Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie's Humira Sales Practices",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Humira",
                        "Investigation",
                        "Sales Practices"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Momenta (MNTA) Reports Narrower-Than-Expected Loss in Q3",
                "features": {
                    "keywords": [
                        "Momenta",
                        "Q3",
                        "Narrower-Than-Expected Loss"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Assessing GW Pharmaceuticalsâ€™ Year-to-Date Performance",
                "features": {
                    "keywords": [
                        "GW Pharmaceuticals",
                        "Year-to-Date Performance"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "6 Pharmaceutical Stocks to Buy After the Midterms",
                "features": {
                    "keywords": [
                        "Pharmaceutical Stocks",
                        "Midterms"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "CLASS ACTION UPDATE for ABBV, HON and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders",
                "features": {
                    "keywords": [
                        "Class Action",
                        "ABBV",
                        "HON",
                        "DY"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "industrials",
                        "materials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug",
                "features": {
                    "keywords": [
                        "LLY",
                        "AZN",
                        "Q3 Earnings",
                        "PFE",
                        "FDA Nod",
                        "Cancer Drug"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "See what the IHS Markit Score report has to say about AbbVie Inc.",
                "features": {
                    "keywords": [
                        "IHS Markit Score",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "AbbVie Characterizes Evolving Hepatitis C (HCV) Patient Landscape in the United States Using Comprehensive Dataset",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Hepatitis C",
                        "HCV",
                        "Patient Landscape",
                        "Comprehensive Dataset"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "AbbVie (ABBV) Gains As Market Dips: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Market Dips"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}